
Coronavirus and Cancer Resources for Survivors
Cancer survivors have expressed concerns and questions about COVID-19, the coronavirus, and how they may be at higher risk due to their cancer history. Here are some resources about COVID-19 generally, and its impact for cancer survivors specifically. NCCS is seeking answers from public health experts on the coronavirus and its impact on cancer patients and survivors. Please leave a comment [...]

Presidential Proclamation — National Childhood Cancer Awareness Month
President Obama announced that the month of September will officially be known as National Childhood Cancer Awareness Month. The proclamation,…
NCCS Submits Comments in Follow-Up to FDA Patient-Focused Public Meeting
NCCS submitted comments to the Food and Drug Administration (FDA) as a follow-up to the Lung Cancer Patient-Focused Drug Development…
NCCS Joins Patient Advocate Colleagues in Commenting on FDA Document on Expedited Programs for Serious Conditions
NCCS joined its patient advocate colleagues in the Cancer Leadership Council in comments on a Food and Drug Administration (FDA) document…
IOM Releases “Partnering with Patients” Meeting Summary
The Institute of Medicine released a meeting summary today of a workshop that took place in February, "Partnering with Patients to…

JAMA Opinion Piece: The Short and Long Term Implications of Myriad Decision
On June 13, 2013, the Supreme Court ruled in Association for Molecular Pathology v. Myriad Genetics that a human gene removed from…
Jessie Gruman’s New York Times Blog Describes Patient’s Post-Discharge Experience
Jessie Gruman offers her fellow cancer survivors and their caregivers specific advice for improving the discussion that occurs between…

The Definition of “Cancer”: JAMA Opinion Piece Triggers Medical, Scientific, and Policy Debate
With the online publication of an opinion piece in the Journal of the American Medical Association, Drs. Laura J. Esserman, Ian M.…
NCCS Comments on Quality Measures for PPS-Exempt Cancer Hospitals
NCCS filed comments in support of proposed cancer care quality measures that will be utilized to assess the cancer care provided by…
Washington Post Wonkblog Discusses Myriad and BRCA Tests
The United States Supreme Court ruled unanimously on June 13, 2013, that human genes cannot be patented. In the case of Association…
Clinical Trials System Evaluation and IOM Workshop Summary
In the Sunday, July 14, New York Times, Clifton Leaf offered a critical evaluation of clinical trials. In letters to the editor published…

